Positives and Negatives
A look at the advantages and disadvantages of current respiratory virus testing methodologies.
Read More
Month: September 2010
Accumetrics, Inc. Increases Capital Raise, Completes Final Close in $24 Million Capital Financing
Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced that it has completed its capital financing efforts, the first round of which was announced in the Fall of 2009.
Read MoreAbbott Molecular, Inc. Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment
Abbott announced it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient’s blood.
Read MorePrometheus Launches Serogenetic Test to Predict Risk of Complications From Crohn’s
Prometheus Laboratories Inc, a specialty pharmaceutical and diagnostic company, announced the commercial launch of its proprietary PROMETHEUS Crohn’s Prognostic test.
Read MoreQIAGEN Introduces QIAsymphony RGQ Automated System for Molecular Testing
QIAGEN NV nnounced the launch of its highly flexible automated solution QIAsymphony RGQ.
Read More